Navigation Links
NYU Cancer Institute experts present at American Society of Clinical Oncology annual meeting
Date:5/21/2010

ress after initial therapy. Recent research shows this VEGF inhibitor may encourage greater invasiveness in patients with newly diagnosed and recurrent HGGs. In the study, researchers assessed tumor recurrence patterns in HGGs and their relation to survival in newly-diagnosed patients treated with bevacizumab. A retrospective analysis was completed for patients with newly diagnosed HGGs initially treated with surgery, radiation therapy, and the drug- temozolomide. Patients were given bevacizumab at 10 mg/kg once every two weeks until disease progression or toxicity. Research shows bevacizumab improve progression free and overall survival in patients. However, researchers concluded there is a marked increase in the number of diffuse recurrences over local recurrences following the additional bevacizumab therapy treatment. This shift in the pattern to diffuse recurrence is worrisome to researchers. Future clinical trials are needed to investigate strategies to block this more invasive progression.


Abstract # 8571: Sunday, June 6 at 12:00 PM in Chicago, IL
Hair Depigmentation as an Indicator of Durable Response to CTLA-4 Therapy
Presenter: Anna C. Pavlick, MS, MD Associate Professor of Medicine and Ronald O. Perelman Department of Dermatology, Director, NYU Melanoma Program, NYU Cancer Institute

Treatment with Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) monoclonal antibodies for metastatic melanoma has been known to induce immunologically related adverse events like skin eruptions and itching in some patients. However, it was unclear if these events are linked with clinical responses. Researchers report, for the first time, the occurrence of hair depigmentation following therapy with CTLA-4 monoclonal antibodies correlates with durable clinical responses. No non-responders to the treatment developed any hair depigmentation. This is the first documentation of hair depigmentation following treatment with CTLA-4 monoclonal antibod
'/>"/>

Contact: Lauren Woods
lauren.woods@nyumc.org
212-404-3753
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Page: 1 2 3 4 5 6

Related biology news :

1. Gene fusions may be the smoking gun in prostate cancer development, U-M study finds
2. Study raises new concerns about radiation and breast cancer
3. Slight changes in 2 key genes appear to launch breast cancer development
4. TGen researcher awarded American Cancer Society fellowship
5. Einstein researcher awarded prestigious cancer research grant
6. Cancer: Trapping the escape artist
7. U-M study achieves reduced side effects in head and neck cancer treatment
8. Milk and risk of renal cell cancer: Genetic research sheds new light
9. Multistage nanovector system provides sustained delivery of siRNA cancer therapeutic in mice
10. Key mechanism identified in metastatic breast cancer
11. Flaxseed-fed chickens shed light on ovarian cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2014)... Research and Markets , ... announced the addition of the "Biometrics Market in ... One major trend emerging in this market is ... utilize more than one characteristic of an individual for ...
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences International (DSI), ... released a new series of digital telemetry implants ... researchers. M series, part of the PhysioTel™ Digital ... best possible physiologic data when incorporating functional endpoints ...
(Date:12/10/2014)... a leader in performance biometric data sensor technology, today ... licensees for highly accurate, clinically validated biometric technology. This ... fitness and health sectors, but first responders/military and gaming ... as useful as the biometric data it delivers. As ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... doctor for a blood test generally has to wait a ... can make patients anxious especially in critical cases, such ... so long for laboratories to analyze samples is in no ... must be accompanied by meticulous records, so lab technicians are ...
... Md. (March 1, 2012)The American Physiology Society (APS) has announced ... experimental animals and the sex or gender of humans used ... 13 peer-reviewed journals. This notable requirement for all research study ... be presented in an editorial, " In Pursuit of Scientific ...
... are working to protect living fossil trees in Fiji from ... Dr Peter Prentis, from QUT,s Science and Engineering Faculty, ... diversity is generated. "Fiji is a hotspot for biodiversity. ... anywhere else in the world," he said. "My project ...
Cached Biology News:'Labor der Zukunft' -- Tomorrow's laboratory technology 2'Labor der Zukunft' -- Tomorrow's laboratory technology 3APS issues new policy requiring identification of sex or gender in reporting scientific research 2APS issues new policy requiring identification of sex or gender in reporting scientific research 3Protecting living fossil trees 2
(Date:1/22/2015)... 22, 2015 Controlled Substance Compliance Services ... helps companies check the legal requirements around using controlled ... China. , As their international operations expand and ... software solutions built as a result of the first ...
(Date:1/22/2015)... ALTO, Calif. , Jan. 22. 2015  Varian Medical Systems ... and software, has been honored for its commitment to sustainability ... sustainable companies. Varian is the highest ranked healthcare equipment company ... announced today during the World Economic Forum at ...
(Date:12/24/2014)... DALLAS and NEW YORK , ... a biopharmaceutical company advancing patient care in critical areas, announced ... of common stock, and warrants to purchase up to an ... of $4.00 per share and $.01 per warrant.  The warrants ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 Earlier this year ... Sherley, director of the Adult Stem Cell Technology Center, LLC ... under appreciated unique property of adult tissue stem cells. ... the Past, Important for the Future,” embodied the essence of ...
Breaking Biology Technology:Global Compliance Service for Controlled Substances to Expand to China 2Varian Honored Among World's 100 Most Sustainable Corporations 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... Oct. 1 CorVel Corporation,(Nasdaq: CRVL ), ... announced the addition of over 150,000 facility and,provider ... November 1, 2007. The new provider network additions ... Health Plan (IHP) headquartered,in St. Petersburg, FL. ...
... Oct. 1 Biomaxx Systems Inc. (Other,OTC: BMXSF), ... our membership,with Bioenergy Australia for 2007. BioMaxx Systems ... in Australia as a result of,our involvement with ... forum established in 1997 to promote renewable,energy solutions. ...
... Software Is Cost-Effective, Time-Saving, ATLANTA, Oct. ... launch of CliniCom(TM), a revolutionary software platform,designed ... possible,psychiatric conditions. CliniCom(TM), an intuitive, computer ... in mental health settings, gathers information,directly from ...
Cached Biology Technology:CorVel Corporation Medical Provider Network Adds New Providers to Increase Savings and Improve Access to Care 2CorVel Corporation Medical Provider Network Adds New Providers to Increase Savings and Improve Access to Care 3Biomaxx Systems Inc. Renews Membership With Bioenergy Australia 2Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology 2Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology 3
SDS-OutT Precipitation Reagent...
... The new FLA-5000 imaging ... and radioisotopic samples as large ... resolutions as low as 25 ... suitable for protein electrophoresis in ...
SDS-OutT SDS Precipitation Reagent...
... Disposable, clear, APET plastic tray. Ideal for ... those trays used for multipurposes. Pour spouts ... A marker or label may be used ... trays on rockers or shakers for staining ...
Biology Products: